RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
I'rom Group Co Stock

I'rom Group Co Revenue 2024

I'rom Group Co Revenue

17.74 B JPY

Ticker

2372.T

ISIN

JP3105170009

In 2024, I'rom Group Co's sales reached 17.74 B JPY, a -3.33% difference from the 18.35 B JPY sales recorded in the previous year.

The I'rom Group Co Revenue history

YEARREVENUE (undefined JPY)GROSS MARGIN (%)
2026e15.7647,61
2025e15.2749,14
202417.7442,31
202318.3549,40
202215.6946,14
202112.9134,32
202010.5940,22
201910.5838,33
20188.6240,73
20174.8936,85
20164.1127,25
20154.1320,05
20144.0126,68
20136.731,35
201211.0223,86
201113.9927,58
201013.8228,15
200914.4829,79
200813.7329,05
200714.8925,42
200612.3729,14
20054.638,28

I'rom Group Co Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into I'rom Group Co, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by I'rom Group Co from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects I'rom Group Co’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of I'rom Group Co. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into I'rom Group Co’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing I'rom Group Co’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on I'rom Group Co’s growth potential.

I'rom Group Co Revenue, EBIT and net profit per share

DateI'rom Group Co RevenueI'rom Group Co EBITI'rom Group Co Net Income
2026e15.76 B undefined0 undefined2.32 B undefined
2025e15.27 B undefined0 undefined2.21 B undefined
202417.74 B undefined1.13 B undefined1.42 B undefined
202318.35 B undefined3.64 B undefined2.54 B undefined
202215.69 B undefined2.76 B undefined1.96 B undefined
202112.91 B undefined1.07 B undefined1.37 B undefined
202010.59 B undefined1.21 B undefined1.24 B undefined
201910.58 B undefined1.22 B undefined912 M undefined
20188.62 B undefined1.04 B undefined1.56 B undefined
20174.89 B undefined212 M undefined204 M undefined
20164.11 B undefined-480 M undefined-868 M undefined
20154.13 B undefined-772 M undefined-606 M undefined
20144.01 B undefined-402 M undefined-294 M undefined
20136.7 B undefined369 M undefined1.75 B undefined
201211.02 B undefined-433 M undefined-364 M undefined
201113.99 B undefined343 M undefined226 M undefined
201013.82 B undefined-159 M undefined-731 M undefined
200914.48 B undefined57 M undefined-10.88 B undefined
200813.73 B undefined-251 M undefined-932 M undefined
200714.89 B undefined-1.29 B undefined-168 M undefined
200612.37 B undefined209 M undefined137 M undefined
20054.6 B undefined505 M undefined-84 M undefined

I'rom Group Co stock margins

The I'rom Group Co margin analysis displays the gross margin, EBIT margin, as well as the profit margin of I'rom Group Co. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for I'rom Group Co.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the I'rom Group Co's sales revenue. A higher gross margin percentage indicates that the I'rom Group Co retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the I'rom Group Co's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the I'rom Group Co's total revenue generated. When comparing the revenue margin year over year, investors can gauge the I'rom Group Co's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the I'rom Group Co. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the I'rom Group Co's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

I'rom Group Co Margin History

I'rom Group Co Gross marginI'rom Group Co Profit marginI'rom Group Co EBIT marginI'rom Group Co Profit margin
2026e42.31 %0 %14.75 %
2025e42.31 %0 %14.48 %
202442.31 %6.39 %7.98 %
202349.4 %19.83 %13.85 %
202246.14 %17.61 %12.5 %
202134.32 %8.28 %10.64 %
202040.22 %11.39 %11.67 %
201938.33 %11.52 %8.62 %
201840.73 %12.11 %18.07 %
201736.85 %4.34 %4.17 %
201627.25 %-11.67 %-21.1 %
201520.05 %-18.67 %-14.66 %
201426.68 %-10.02 %-7.33 %
201331.35 %5.5 %26.12 %
201223.86 %-3.93 %-3.3 %
201127.58 %2.45 %1.62 %
201028.15 %-1.15 %-5.29 %
200929.79 %0.39 %-75.18 %
200829.05 %-1.83 %-6.79 %
200725.42 %-8.63 %-1.13 %
200629.14 %1.69 %1.11 %
200538.28 %10.99 %-1.83 %

I'rom Group Co Aktienanalyse

What does I'rom Group Co do?

I'rom Group Co. Ltd is a Japanese company specialized in medical services. It was founded in April 2007 and is headquartered in Tokyo, Japan. The company has become a significant player in the medical service sector in Japan within a few years. Its business model focuses on medical services and the sale of medical products, specifically in the areas of Life-Science and Clinical Research. I'rom offers support in clinical studies, distributes medications and medical devices, and provides CRM services. The company is divided into different divisions that offer various specialized products and services such as clinical research services, medical development services, corporate staffing services, and CRM services. I'rom also offers a wide range of medical products, mainly targeting the Japanese market. In conclusion, I'rom Group Co. Ltd is a leading company in the field of medical services in Japan, providing integrated support in product development and marketing for the life science and healthcare industries. I'rom Group Co ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Revenue Details

Understanding I'rom Group Co's Sales Figures

The sales figures of I'rom Group Co originate from the total revenue accrued from goods sold or services provided during a specific time period. These numbers are a direct reflection of the company’s ability to translate its products or services into revenue, indicating the demand and market presence.

Year-to-Year Comparison

Analyzing I'rom Group Co’s yearly sales data offers insights into the company’s growth and stability. An increase in sales suggests a growing demand for its offerings, efficient marketing, or expansion into new markets. Conversely, a decline might indicate market saturation, increased competition, or less effective strategies.

Impact on Investments

Investors often scrutinize I'rom Group Co's sales data to evaluate its financial health and growth prospects. Consistent sales growth can be a promising indicator of the company’s profitability and potential return on investment, influencing stock prices and investor confidence.

Interpreting Sales Fluctuations

Increases in I'rom Group Co’s sales indicate market growth, innovation, or effective marketing, often leading to a surge in stock prices. A decline, however, can signal challenges requiring strategic adjustments to enhance market share and profitability.

Frequently Asked Questions about I'rom Group Co stock

How much revenue did I'rom Group Co generate this year?

I'rom Group Co has achieved a revenue of 17.74 B JPY this year.

How much was the turnover of the company I'rom Group Co compared to the previous year?

The revenue of I'rom Group Co has increased by -3.33% decreased compared to the previous year.

What does revenue mean for investors?

The revenue of a company is an important indicator of its financial performance and attractiveness for investors.

Which factors influence the revenue of I'rom Group Co?

The revenue of I'rom Group Co is influenced by various factors, including the demand for its products and services, market conditions, and prices.

How is the revenue of I'rom Group Co measured?

Revenue is typically measured in units referring to the sale of goods and services provided by the company.

How does an increase in sales affect investments?

An increase in revenue can prompt investors to invest more money in the company as it serves as a positive signal for its financial performance and growth prospects.

What are the possible risks associated with a declining revenue?

A decline in revenue can prompt investors to invest less money in the company, as it is a negative signal for its financial performance and growth prospects.

Why is the sales revenue of I'rom Group Co so important for investors?

The revenue of I'rom Group Co is an important indicator of financial performance and attractiveness for investors.

What strategic measures can a company take to increase revenue?

A company can take various strategic measures to increase revenue, including developing new products and services, introducing new pricing models, and expanding into new markets.

How much dividend does I'rom Group Co pay?

Over the past 12 months, I'rom Group Co paid a dividend of 40 JPY . This corresponds to a dividend yield of about 1.44 %. For the coming 12 months, I'rom Group Co is expected to pay a dividend of 45.32 JPY.

What is the dividend yield of I'rom Group Co?

The current dividend yield of I'rom Group Co is 1.44 %.

When does I'rom Group Co pay dividends?

I'rom Group Co pays a quarterly dividend. This is distributed in the months of October, April, October, April.

How secure is the dividend of I'rom Group Co?

I'rom Group Co paid dividends every year for the past 10 years.

What is the dividend of I'rom Group Co?

For the upcoming 12 months, dividends amounting to 45.32 JPY are expected. This corresponds to a dividend yield of 1.63 %.

In which sector is I'rom Group Co located?

I'rom Group Co is assigned to the 'Health' sector.

Wann musste ich die Aktien von I'rom Group Co kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of I'rom Group Co from 6/1/2024 amounting to 40 JPY, you needed to have the stock in your portfolio before the ex-date on 3/28/2024.

When did I'rom Group Co pay the last dividend?

The last dividend was paid out on 6/1/2024.

What was the dividend of I'rom Group Co in the year 2023?

In the year 2023, I'rom Group Co distributed 65 JPY as dividends.

In which currency does I'rom Group Co pay out the dividend?

The dividends of I'rom Group Co are distributed in JPY.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von I'rom Group Co

Our stock analysis for I'rom Group Co Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of I'rom Group Co Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.